Intravenous methylprednisolone pulses in hospitalised patients with severe COVID-19 pneumonia: a double-blind, randomised, placebo-controlled trial.

"Conflict of interest: The authors declare no competing interests."

"Support statement: This research received no external funding. The coordinator centre and participating centres used local resources to conduct the trial."

"Statistical analyses were performed using SAS (version 9.4; SAS Institute) and SPSS (version 23; IBM Corporation). The trial is registered with EudraCT (2020-004323-16) and ClinicalTrials.gov (NCT04673162). This study is registered with EudraCT, 2020-004323-16, and at ClinicalTrials.gov with identifier NCT04673162. De-identified participant data including data dictionaries will be made available within 3 months of publication. The proposed use of the data and analyses must be approved by the scientific committee before to have access to the data. The scientific committee will have the right to review and comment any draft manuscripts prior to publication. Those wishing to request access should write to the corresponding author."